Identification of pyruvate kinase in methicillin-resistant Staphylococcus aureus as a novel antimicrobial drug target.
about
Recent Advances in Drug Discovery from South African Marine InvertebratesDiscovery of anthelmintic drug targets and drugs using chokepoints in nematode metabolic pathwaysMethicillin-resistant Staphylococcus aureus (MRSA) Pyruvate Kinase as a Target for Bis-indole Alkaloids with Antibacterial ActivitiesGlycolytic dependency of high-level nitric oxide resistance and virulence in Staphylococcus aureus.Targeting druggable enzymome by exploiting natural medicines: An in silico-in vitro integrated approach to combating multidrug resistance in bacterial infection.Central Role of Pyruvate Kinase in Carbon Co-catabolism of Mycobacterium tuberculosis.Network-assisted investigation of virulence and antibiotic-resistance systems in Pseudomonas aeruginosaAmino Acid Catabolism in Staphylococcus aureus and the Function of Carbon Catabolite Repression.Phosphorylation of pyruvate kinase A by protein kinase J leads to the altered growth and differential rate of intracellular survival of mycobacteria.Coordinating bacterial cell division with nutrient availability: a role for glycolysisNovel inhibitors of the methicillin-resistant Staphylococcus aureus (MRSA)-pyruvate kinase.Discovery and optimization of a new class of pyruvate kinase inhibitors as potential therapeutics for the treatment of methicillin-resistant Staphylococcus aureus infections.Novel synthetic bis-indolic derivatives with antistaphylococcal activity, including against MRSA and VISA strains.Silver Oxide Coatings with High Silver-Ion Elution Rates and Characterization of Bactericidal Activity.Characteristics of revisits of children at risk for serious infections in pediatric emergency care.In Staphylococcus aureus the regulation of pyruvate kinase activity by serine/threonine protein kinase favors biofilm formation.Targeting fundamental pathways to disrupt Staphylococcus aureus survival: clinical implications of recent discoveries.
P2860
Q26782430-EADDAE52-B7EE-42B6-94ED-DE0791663A0FQ27334315-F12E1A66-BEAB-42B1-83F5-92E092D101A7Q27675245-E32F3EFB-641B-4A41-BCD7-273379EF3378Q35677542-47E9C0F2-5190-49FE-B7F0-357D702AA89DQ35872631-8D037413-A5DA-4B9D-977F-86CB7992B451Q36727448-80F95721-FB55-4C56-B5CE-6F587BEA9D21Q36914772-2559B4F2-99BB-4D2E-9DDB-5EBB6A1044A0Q38961581-D9F6157F-B2EB-4886-A4AD-0F852AEB7380Q38984252-8FD63F6C-E674-4FFC-83DF-A4C6E66C880EQ39859375-96D65973-DD7E-4357-AD69-51D2FE410329Q40876981-3E6BF4D9-53F0-4C0A-9243-51C9F4FE46FCQ42229272-007171E3-9467-4B07-959E-4F00923FE44BQ46771227-6A71EA7C-CB43-46F0-BC81-080D1DCF374BQ47706071-9811B47A-A51B-4985-AA4B-F9655A56DA6AQ48110826-C25D4973-EE6E-4185-839C-285D8D6D0D79Q53907233-FB8096DE-0D89-40BB-A684-5B8D6CF26347Q54975873-B172421D-80ED-44C0-AADF-02ED400AA4F4
P2860
Identification of pyruvate kinase in methicillin-resistant Staphylococcus aureus as a novel antimicrobial drug target.
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Identification of pyruvate kin ...... vel antimicrobial drug target.
@ast
Identification of pyruvate kin ...... vel antimicrobial drug target.
@en
type
label
Identification of pyruvate kin ...... vel antimicrobial drug target.
@ast
Identification of pyruvate kin ...... vel antimicrobial drug target.
@en
prefLabel
Identification of pyruvate kin ...... vel antimicrobial drug target.
@ast
Identification of pyruvate kin ...... vel antimicrobial drug target.
@en
P2093
P2860
P356
P1476
Identification of pyruvate kin ...... ovel antimicrobial drug target
@en
P2093
Anne Moreau
Artem Cherkasov
B Brett Finlay
Christophe Labriere
Emily Amandoron
Huansheng Gong
Jihong Jiang
Leonard Foster
Liam Worrall
Linda Jackson
P2860
P304
P356
10.1128/AAC.01250-10
P407
P577
2011-02-28T00:00:00Z